FDA panel on peptides will include experts who promote unproven chemicals favored by RFK Jr.

The U.S.

Food and Drug Administration (FDA) is convening a panel next month to consider easing restrictions on several peptides, a group of unapproved drugs popular among followers of Robert F. Kennedy Jr. This meeting…